Dear colleagues,

It is with great pleasure that we invite you to join us at the Clinical Trials and Innovation in Asian Oncology: from bench to bedside, taking place on May 15-16, 2025 in the vibrant city of Tokyo, Japan. This premier event, co-organized with Euroleukemia, will unite leading clinicians, researchers, and industry professionals from around the world to explore the latest advances in oncology and hematology.

Building on the success of EuroLeuk 2020 and EuroLeuk 2021, Clinical trials and Innovation in Asian Oncology continues its mission to provide cutting-edge scientific insights and promote innovation in the field. Join us for a unique opportunity to engage in discussions on the most critical topics in patient care, clinical trials, and therapeutic advancements in oncology and hematology.

In addition to the rich scientific program, accepted abstracts will be published in Frontiers journal, offering great visibility for your research.

Alessandro Isidori, MD, PhD,

Hematology and Stem Cell Transplant Center

Marche Nord Hospital – Pesaro – Italy

Chief Editor for “Frontiers in Oncology”

Congress Chair